|
Volumn 178, Issue 2, 2009, Pages 235-236
|
Comment on Shuhaibar et al.: Favourable effect of immunomodulator therapy on bone mineral density in multiple sclerosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA1A INTERFERON;
GLATIRAMER;
IMMUNOMODULATING AGENT;
INTERFERON BETA SERINE;
METHYLPREDNISOLONE;
BETA INTERFERON;
IMMUNOLOGIC FACTOR;
IMMUNOLOGICAL ADJUVANT;
IMMUNOSUPPRESSIVE AGENT;
PEPTIDE;
BODY MASS;
BONE DENSITOMETRY;
BONE DENSITY;
DISEASE DURATION;
DRUG PULSE THERAPY;
FEMUR;
HUMAN;
LUMBAR SPINE;
MULTIPLE SCLEROSIS;
NOTE;
RELAPSE;
ADULT;
CASE CONTROL STUDY;
DRUG EFFECTS;
FEMALE;
MALE;
MIDDLE AGED;
ADJUVANTS, IMMUNOLOGIC;
ADULT;
BONE DENSITY;
CASE-CONTROL STUDIES;
FEMALE;
HUMANS;
IMMUNOLOGIC FACTORS;
IMMUNOSUPPRESSIVE AGENTS;
INTERFERON-BETA;
MALE;
MIDDLE AGED;
MULTIPLE SCLEROSIS;
PEPTIDES;
|
EID: 67649559483
PISSN: 00211265
EISSN: None
Source Type: Journal
DOI: 10.1007/s11845-009-0275-y Document Type: Note |
Times cited : (5)
|
References (1)
|